Adam Veness
General Counsel en DIANTHUS THERAPEUTICS, INC. .
Fortuna: - $ al 31/03/2024
Cargos activos de Adam Veness
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
DIANTHUS THERAPEUTICS, INC. | General Counsel | 11/09/2023 | - |
Corporate Secretary | 11/09/2023 | - |
Historial de carrera de Adam Veness
Antiguos cargos conocidos de Adam Veness.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
CYTEIR THERAPEUTICS, INC. | General Counsel | 25/04/2022 | 14/06/2023 |
Corporate Secretary | - | 14/06/2023 | |
ACCELERON PHARMA INC. | Compliance Officer | 01/07/2014 | 01/06/2019 |
General Counsel | 01/06/2019 | 01/12/2021 | |
Corporate Secretary | 01/06/2019 | - | |
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC Miscellaneous Commercial ServicesCommercial Services Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC provides legal services. The firm offers services to the communications, education, environmental, health, immigration, public finance, real estate and tax industries. The company was founded in 1933 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/01/2012 | 01/07/2014 |
Formación de Adam Veness.
Tulane University (Louisiana) | Undergraduate Degree |
Boston University School of Law | Graduate Degree |
Estadísticas
Internacional
Estados Unidos | 7 |
Operativa
General Counsel | 3 |
Corporate Secretary | 3 |
Compliance Officer | 1 |
Sectorial
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
CYTEIR THERAPEUTICS, INC. | Health Technology |
DIANTHUS THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Acceleron Pharma, Inc.
Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC Miscellaneous Commercial ServicesCommercial Services Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC provides legal services. The firm offers services to the communications, education, environmental, health, immigration, public finance, real estate and tax industries. The company was founded in 1933 and is headquartered in Boston, MA. | Commercial Services |
- Bolsa de valores
- Insiders
- Adam Veness
- Experiencia